5 results
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Overview of Treatment Agents ... 4/11/2020 #Drugs ... #Medications #Treatment ... #COVID19 #Pharmacology ... #Table #Management
Vasopressors and Inotropes
 • Norepinephrine - Levophed - "Levo" - Generally thought of as the first
common in OR; in MICU ... Vasopressors #Inotropes #management ... #criticalcare # ... summary #comparison #table ... #pharmacology #
Pain, Agitation, and Delirium (PAD) in the ICU
Addressing the ICU Triad (PAD) can be accomplished through
A dissociative drug ... non-OTC prolonging agent ... No pharmacologic ... #CriticalCare # ... diagnosis #management
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
Weaknesses: High MIC ... Weaknesses: Therapeutic drug ... #medications #Coccidioidomycosis ... #pharmacology # ... management #treatment
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
of antifungal agents ... tolerable • High MIC ... • Therapeutic drug ... #valleyfever #management ... #pharmacology